Hapgen ®  is New Class A  Drug in China with intellectual property rights. It has antiviral, anti-tumor and immunoregulatory benifits, and is effective and safe to use in several areas including pediatric viruses, viral hepatitis, oncology, hematology and skin diseases. Experts in the field have conducted extensive clinical trials with several important findings.